Trastuzumab - Globe Thesis

Keyword [Trastuzumab] Result: 121 - 140 \| Page: 7 of 8
121.	An Analytical Study On The Cardiotoxicity Of Anthracycline And Trastuzumab In The Treatment Of Her-2 Positive Breast Cancer
122.	Mimotope Peptide Modified Biomimetic Polymer For Purification And Quantification Of Trastuzumab
123.	Molecular Imaging as a Tool for Predicting and Monitoring Response of Breast Cancer to Trastuzumab (Herceptin)
124.	The role of natural killer cells in the response to anti-tumor antibodies
125.	Development, Characterization and Validation of Trastuzumab-Modified Gold Nanoparticles for Molecularly Targeted Radiosensitization of Breast Cancer
126.	Impact of HER-2/neu detection by fluorescence in situ hybridization (FISH) on trastuzumab therapy in the treatment of metastatic breast cancer
127.	Trastuzumab-metal chelating polymer (MCP) radioimmunoconjugates for Auger electron radioimmunotherapy of breast cancer
128.	The Role of t-Darpp in Trastuzumab Resistance
129.	Linear epitopes that generate anti-HER-2 antibody responses with trastuzuab- (herceptin) like biological activity
130.	Trastuzumab Phthalocyanine Micelle Preparation And Application On Diagnostic Imaging Of Colorectal Cancer Metastatic Lymph Nodes
131.	Bioinformatics Analysis Of Microsatellite Instability And Tumor Immune Features In Colorectal Cancer
132.	PFKFB3 Promotes Vessel Abnormalization Induced HER2 Positive Gastric Cancer Trastuzumab Resistance By Targeting Smad3 S425 Phosphorylation Mediated CXCL8 Extracellular Secretion
133.	The Clinical Research Of GEMOX Or GEMOX Plus Molecular Targeted Drugs In Patients With Biliary Tract Cancer
134.	Trastuzumab Reverses Chemotherapy Resistance Induced By ABCG2 In HER2-positive Gastric Cancer Through PI3K-AKT
135.	The Study Of Targeted Inhibition Of HER2-SHCBP1-PLK1 Non-canonical Pathway To Sensitize Trastuzumab In Gastric Cancer
136.	BMAL1-CLOCK-PER1 Regulates Glycolytic Biorhythms To Mediate Trastuzumab Resistance In HER2-positive Gastric Cancer
137.	Exploratory Research Of Optimal Anti-HER2 Targeted Therapy And Resistance Mechanism
138.	The Exploratory Study Of Trastuzumab Resistant Mechanism In Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Using Circulating Tumor Cells
139.	Influence Of YAP On Resistance Of HER2-Positive Breast Cancer Cells To Trastuzumab And Related Mechanisms
140.	The Mechanism Of IL-6/IL-6R In Promoting Trastuzumab Resistance In Breast Cancer
<<First <Prev Next> Last>> Jump to